Gene expression profiling of the response of esophageal carcinoma cells to cisplatin

Diseases of the Esophagus

Volumn 21, Issue 3, 2008, Pages 230-235

  Takashima, N ^a   Ishiguro, Hideyuki ^a   Kuwabara, Y ^a   Kimura, M ^a   Mitui, A ^a   Mori, Y ^a   Mori, R ^a   Tomoda, K ^a   Hamaguchi, M ^a   Ogawa, R ^a   Katada, T ^a   Harada, K ^a   Fujii, Y ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Cisplatin; Esophageal cancer; Microarray

Indexed keywords

ANTERIOR GRADIENT HOMOLOG PROTEIN 2; BETA TUBULIN; BETA4 TUBULIN; CELL PROTEIN; CHAPERONIN; CISPLATIN; CYTOKERATIN 17; DECAY ACCELERATING FACTOR; DICKKOPF HOMOLOG PROTEIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERYTHROPOIETIN 4 IMMEDIATE EARLY RESPONSE PROTEIN; FLIGHTLESS HOMOLOG PROTEIN I; GOLGI PHOSPHOPROTEIN 2; METAXIN 2; MITOCHONDRIAL CARRIER HOMOLOG PROTEIN 2; N ACETYLGALACTOSAMINYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE 1; NUCLEAR RECEPTOR COREPRESSOR; NUCLEAR RECEPTOR COREPRESSOR 1; NUCLEOLAR PROTEIN 5A; OSTEOGENIC PROTEIN 1; PERIPHERAL MYELIN PROTEIN 22; PLECTIN; PLECTIN 1; RGS2 PROTEIN; STEROID 5ALPHA REDUCTASE 2; STEROID 5ALPHA REDUCTASE 2 LIKE; THROMBOSPONDIN 1; TRIPARTITE MOTIF PROTEIN 16; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4;

ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER RESISTANCE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN KYSE150; CELL STRAIN TE1; CELL STRAIN TE10; CELL STRAIN TE11; CELL STRAIN TE12; CELL STRAIN TE13; CELL STRAIN TE14; CELL STRAIN TE15; CELL STRAIN TE2; CELL STRAIN TE3; CELL STRAIN TE4; CELL STRAIN TE5; CELL STRAIN TE8; CELL STRAIN TE9; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG SENSITIVITY; EPITHELIUM CELL; ESOPHAGUS CARCINOMA; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; RNA EXTRACTION; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS;

EID: 42649086494     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00761.x     Document Type: Article

References (26)

1. Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino J R. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 2002; 1587: 164-73.
2. Brabec V, Kasparkova J. Molecular aspects of resistance to antitumor platinum drugs. Drug Resist Updat 2002; 5: 147-61.
3. Weiss R B, Christian M C. New cisplatin analogues in development. A Rev Drugs 1993; 46: 360-77.
4. Holford J, Beale P J, Boxall F E, Sharp S Y, Kelland L R. Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines. Eur J Cancer 2000; 36: 1984-90.
5. Larsen A K, Escargueil A E, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000; 85: 217-29.
6. Rosell R, Lord R V, Taron M, Reguart N. DNA repair and cisplatin resistance in non-small-cell lung cancer. Lung Cancer 2002; 38: 217-27.
7. Li J, Wood W H III, Becker K G, Weeraratna A T, Morin P J. Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells. Oncogene 2007; 26: 2860-72.
8. Luo L, Salunga R C, Guo H et al. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 1999; 5: 117-22.
9. Van Gelder R N, von Zastrow M E, Yool A, Dement W C, Barchas J D, Eberwine J H. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 1990; 87: 1663-7.
10. Kitahara O, Furukawa Y, Tanaka T et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 2001; 61: 3544-9.
11. Ono K, Tanaka T, Tsunoda T et al. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res 2000; 60: 5007-11.
12. DeRisi J, Penland L, Brown P O et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996; 14: 457-60.
13. Khan J, Simon R, Bittner M et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998; 58: 5009-13.
14. Schena M, Shalon D, Davis R W, Brown P O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-70.
15. Alizadeh A A, Eisen M B, Davis R E et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
16. Golub T R, Slonim D K, Tamayo P et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7.
17. Scherf U, Ross D T, Waltham M et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000; 24: 236-44.
18. Dan S, Tsunoda T, Kitahara O et al. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res 2002; 62: 1139-47.
19. Kudoh K, Ramanna M, Ravatn R et al. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 2000; 60: 4161-6.
20. Staunton J E, Slonim D K, Coller H A et al. Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA 2001; 98: 10787-92.
21. Wittig R, Nessling M, Will R D et al. Candidate genes for cross-resistance against DNA-damaging drugs. Cancer Res 2002; 62: 6698-705.
22. Hu Y C, Lam K Y, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array. overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001; 7: 2213-21.
23. Husain A, He G, Venkatraman E S, Spriggs D R. BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum (II). Cancer Res 1998; 58: 1120-3.
24. Lenz H J, Leichman C G, Danenberg K D et al. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival. J Clin Oncol 1996; 14: 176-82.
25. Alvarez A A, Axelrod J R, Whitaker R S et al. Thrombospondin-1 expression in epithelial ovarian carcinoma: Association with p53 status, tumor angiogenesis, and survival in platinum-treated patients. Gynecol Oncol 2001; 82: 273-8.
26. Yu D, Jing T, Liu B et al. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Mol Cell 1998; 2: 581-91.